Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Maryland
Sponsor:
Information provided by (Responsible Party):
Susan Kesmodel, University of Maryland
ClinicalTrials.gov Identifier:
NCT02095184
First received: March 20, 2014
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2019
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)